GM-2040
GM-2040 is a putatively non-hallucinogenic serotonin 5-HT 2A receptor agonist which was developed by Gilgamesh Pharmaceuticals.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
GM-2040 is a putatively non-hallucinogenic serotonin 5-HT 2A receptor agonist which was developed by Gilgamesh Pharmaceuticals. It is a partial agonist of the serotonin 5-HT 2A receptor, with a K i of 3.4 nM, an of 43.8 nM, and an of 71.1%.
Relative to the serotonergic psychedelic DOPR, the drug only weakly produces the head-twitch response (HTR), a behavioral proxy of psychedelic effects, in rodents, and hence may not produce hallucinogenic effects in humans. On the other hand, GM-2040 shows robust and persistent antidepressant-like effects in rodents.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1317616446 under CC BY-SA 4.0; modifications have been made.